Jose Alfredo Blakeley-Ruiz

Jose Alfredo Blakeley-Ruiz

Auto-generated profile, based on publicly available information

Jose Alfredo Blakeley-Ruiz

Department of Plant and Microbial Biology, North Carolina State University, Raleigh, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2025 in iMeta
Verified
Journal Article
Open access
TBTim Van Den Bossche
Tim Van Den Bossche
Jean ArmengaudJean Armengaud
Jean Armengaud
DBDirk Benndorf
Dirk Benndorf
JBJose Alfredo Blakeley‐Ruiz
Jose Alfredo Blakeley‐Ruiz
MBMadita Brauer
Madita Brauer
TIThe Metaproteomics Initiative
The Metaproteomics Initiative
Metaproteomics is an emerging approach for studying microbiomes, offering the ability to characterize proteins that underpin microbial functionality within diverse ecosystems. As the primary catalytic and structural components of microbiomes, proteins provide unique insights into the active processes and ecological roles of microbial communities. By integrating metaproteomics with other omics disciplines, researchers can gain a comprehensive understanding of microbial ecology, interactions, and functional dynamics. This review, developed by the Metaproteomics Initiative (www.metaproteomics.org), serves as a practical guide for both microbiome and proteomics researchers, presenting key principles, state‐of‐the‐art methodologies, and analytical workflows essential to metaproteomics. Topics covered include experimental design, sample preparation, mass spectrometry techniques, data analysis strategies, and statistical approaches.

11 February 2019 in Microbiome
Verified
Journal Article
Open access
PDF file
JBJ. Alfredo Blakeley-Ruiz
J. Alfredo Blakeley-Ruiz
AEAlison R. Erickson
Alison R. Erickson
BCBrandi L. Cantarel
Brandi L. Cantarel
WXWeili Xiong
Weili Xiong
RARachel Adams
Rachel Adams
RHRobert Hettich
Robert Hettich
The gut microbiome plays a fundamental role in the human host’s overall health by contributing key biological functions such as expanded metabolism and pathogen defense/immune control. In a healthy individual, the gut microbiome co-exists within the human host in a symbiotic, non-inflammatory relationship that enables mutual benefits, such as microbial degradation of indigestible food products into small molecules that the host can utilize, and enhanced pathogen defense. In abnormal conditions, such as Crohn’s disease, this favorable metabolic relationship breaks down and a variety of undesirable activities result, including chronic inflammation and other health-related issues. It has been difficult, however, to elucidate the overall functional characteristics of this relationship because the microbiota can vary substantially in composition for healthy humans and possibly even more in individuals with gut disease conditions such as Crohn’s disease. Overall, this suggests that microbial membership composition may not be the best way to characterize a phenotype. Alternatively, it seems to be more informative to examine and characterize the functional composition of a gut microbiome. Towards that end, this study examines 25 metaproteomes measured in several Crohn’s disease patients’ post-resection surgery across the course of 1 year, in order to examine persistence of microbial taxa, genes, proteins, and metabolic functional distributions across time in individuals whose microbiome might be more variable due to the gut disease condition. The measured metaproteomes were highly personalized, with all the temporally-related metaproteomes clustering most closely by individual. In general, the metaproteomes were remarkably distinct between individuals and to a lesser extent within individuals. This prompted a need to characterize the metaproteome at a higher functional level, which was achieved by annotating identified protein groups with KEGG orthologous groups to infer metabolic modules. At this level, similar and redundant metabolic functions across multiple phyla were observed across time and between individuals. Tracking through these various metabolic modules revealed a clear path from carbohydrate, lipid, and amino acid degradation to central metabolism and finally the production of fermentation products. The human gut metaproteome can vary quite substantially across time and individuals. However, despite substantial intra-individual variation in the metaproteomes, there is a clear persistence of conserved metabolic functions across time and individuals. Additionally, the persistence of these core functions is redundant across multiple phyla but is not always observable in the same sample. Finally, the gut microbiome’s metabolism is not driven by a set of discrete linear pathways but a web of interconnected reactions facilitated by a network of enzymes that connect multiple molecules across multiple pathways.

10 April 2025 in Proteomics
Verified
Journal Article
Open access
ARAndrew Rajczewski
Andrew Rajczewski
JBJ. Alfredo Blakeley‐Ruiz
J. Alfredo Blakeley‐Ruiz
AMAnnaliese Meyer
Annaliese Meyer
SVSimina Vintila
Simina Vintila
MMMatthew R. McIlvin
Matthew R. McIlvin
Pratik JagtapPratik Jagtap
Pratik Jagtap
Mass spectrometry (MS)‐based metaproteomics is used to identify and quantify proteins in microbiome samples, with the frequently used methodology being data‐dependent acquisition mass spectrometry (DDA‐MS). However, DDA‐MS is limited in its ability to reproducibly identify and quantify lower abundant peptides and proteins. To address DDA‐MS deficiencies, proteomics researchers have started using Data‐independent acquisition mass spectrometry (DIA‐MS) for reproducible detection and quantification of peptides and proteins. We sought to evaluate the reproducibility and accuracy of DIA‐MS metaproteomic measurements relative to DDA‐MS using a mock community of known taxonomic composition. Artificial microbial communities of known composition were analyzed independently in three laboratories using DDA‐ and DIA‐MS acquisition methods. In this study, DIA‐MS yielded more protein and peptide identifications than DDA‐MS in each laboratory for the particular instruments and software parameters chosen. In addition, the protein and peptide identifications were more reproducible in all laboratories and provided an accurate quantification of proteins and taxonomic groups in the samples. We also identified some limitations of current DIA tools when applied to metaproteomic data, highlighting specific needs to improve DIA tools enabling analysis of metaproteomic datasets from complex microbiomes. Ultimately, DIA‐MS represents a promising strategy for MS‐based metaproteomics due to its large number of detected proteins and peptides, reproducibility, deep sequencing capabilities, and accurate quantitation.

29 July 2025 in Food & Function
Verified
Journal Article
Open access
PDF file
AAAyesha Awan
Ayesha Awan
ABAlexandria Bartlett
Alexandria Bartlett
JBJ. Alfredo Blakeley-Ruiz
J. Alfredo Blakeley-Ruiz
TRTanner Richie
Tanner Richie
CTCasey M. Theriot
Casey M. Theriot
MKManuel Kleiner
Manuel Kleiner
The source of protein impacts the quantity and type of dietary proteins reaching the large intestine and interacting with gut microbes. Proteins from even highly digestible sources escape digestion and are modified by the gut microbiota in the colon.

5 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JBJ. Alfredo Blakeley-Ruiz
J. Alfredo Blakeley-Ruiz
ABAlexandria Bartlett
Alexandria Bartlett
AMArthur McMillan
Arthur McMillan
AAAyesha Awan
Ayesha Awan
MWMolly Vanhoy Walsh
Molly Vanhoy Walsh
MKManuel Kleiner
Manuel Kleiner
The source of protein in a person’s diet affects their total life expectancy1–3. However, the mechanisms by which dietary protein sources differentially impact human health and life expectancy are poorly understood2,4. Dietary choices have major impacts on the composition and function of the intestinal microbiota that ultimately mediate host health5–7. This raises the possibility that health outcomes based on dietary protein sources might be driven by interactions between dietary protein and the gut microbiota. In this study, we determine the effects of seven different sources of dietary protein on the gut microbiota in mice. We apply an integrated metagenomics-metaproteomics approach to simultaneously investigate the effects of these dietary protein sources on the gut microbiota’s composition and function. The protein abundances measured by metaproteomics can provide microbial species abundances8, and evidence for the phenotype of microbiota members on the molecular level because measured proteins allow us to infer the metabolic and physiological processes used by a microbial community9. We showed that dietary protein source significantly altered the species composition and overall function of the gut microbiota. Different dietary protein sources led to changes in the abundance of microbial amino acid degrading proteins and proteins involved in the degradation of glycosylations on dietary protein. In particular, brown rice and egg white protein increased the abundance of amino acid degrading enzymes and egg white protein increased the abundance of bacteria and proteins usually associated with the degradation of the intestinal mucus barrier. These results show that dietary protein source can change the gut microbiota’s metabolism, which could have major implications in the context of gut microbiota mediated diseases.

21 February 2025 in Proteomics
Verified
Journal Article
Open access
ABAlexandria Bartlett
Alexandria Bartlett
JBJ. Alfredo Blakeley‐Ruiz
J. Alfredo Blakeley‐Ruiz
TRTanner Richie
Tanner Richie
CTCasey M. Theriot
Casey M. Theriot
MKManuel Kleiner
Manuel Kleiner
Diet has been shown to greatly impact the intestinal microbiota. To understand the role of individual dietary components, defined diets with purified components are frequently used in diet‐microbiota studies. Defined diets frequently use purified casein as the protein source. Previous work indicated that casein contains microbial DNA potentially impacting results of microbiome studies. Other diet‐based microbially derived molecules that may impact microbiome measurements, such as proteins detected by metaproteomics, have not been determined for casein. Additionally, other protein sources used in microbiome studies have not been characterized for their microbial content. We used metagenomics and metaproteomics to identify and quantify microbial DNA and protein in a casein‐based defined diet to better understand potential impacts on metagenomic and metaproteomic microbiome studies. We further tested six additional defined diets with purified protein sources with an integrated metagenomic–metaproteomic approach and found that contaminating microbial protein is unique to casein within the tested set as microbial protein was not identified in diets with other protein sources. We also illustrate the contribution of diet‐derived microbial protein in diet‐microbiota studies by metaproteomic analysis of stool samples from germ‐free mice (GF) and mice with a conventional microbiota (CV) following consumption of diets with casein and non‐casein protein. This study highlights a potentially confounding factor in diet‐microbiota studies that must be considered through evaluation of the diet itself within a given study.